197 related articles for article (PubMed ID: 16924280)
1. Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study.
Shetty S; Dawes P; Ruske D; Al-qudah M; Lyons B
N Z Med J; 2006 Aug; 119(1240):U2129. PubMed ID: 16924280
[TBL] [Abstract][Full Text] [Related]
2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
3. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands].
Carod Artal FJ
Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling.
Marina MB; Sani A; Hamzaini AH; Hamidon BB
J Laryngol Otol; 2008 Jun; 122(6):609-14. PubMed ID: 17640435
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
Alataş N; Yazgan P; Oztürk A; San I
Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):49-53. PubMed ID: 16763416
[TBL] [Abstract][Full Text] [Related]
8. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
Sidebottom AJ; May JE; Madahar AK
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
[TBL] [Abstract][Full Text] [Related]
9. Successful management of drooling with botulinum toxin A in neurologically disabled children.
Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
Sriskandan N; Moody A; Howlett DC
Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
[TBL] [Abstract][Full Text] [Related]
11. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
Restivo DA; Panebianco M; Casabona A; Lanza S; Marchese-Ragona R; Patti F; Masiero S; Biondi A; Quartarone A
Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29382036
[No Abstract] [Full Text] [Related]
13. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
Su CS; Lan MY; Liu JS; Chang CC; Lai SL; Wu HS; Chen SS; Chang YY
Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivation.
Gerlinger I; Szalai G; Hollódy K; Németh A
J Laryngol Otol; 2007 Oct; 121(10):947-51. PubMed ID: 17391573
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA; Berini Aytés L; Gay Escoda C
Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
[TBL] [Abstract][Full Text] [Related]
17. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
19. The effect of local injection of botulinum toxin A on the immunoreactivity of nNOS in the rat submandibular gland: an immunohistochemical study.
Ellies M; Schütz S; Quondamatteo F; Laskawi R
Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):59-63. PubMed ID: 16002154
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injections for new onset bilateral vocal fold motion impairment in adults.
Ekbom DC; Garrett CG; Yung KC; Johnson FL; Billante CR; Zealear DL; Courey MS
Laryngoscope; 2010 Apr; 120(4):758-63. PubMed ID: 20213793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
